Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIEHS

Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions

  • Read more about Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions
European Patent
05750004.3
Filed on 2005-05-12

Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions

  • Read more about Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions
Canada
2566445
Filed on 2005-05-12

Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions

  • Read more about Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions
Australia
2005244852
Filed on 2005-05-12

DMT-DERIVATIVE COMPOUNDS AND RELATED COMPOSITIONS AND METHODS OF USE

  • Read more about DMT-DERIVATIVE COMPOUNDS AND RELATED COMPOSITIONS AND METHODS OF USE
Patent Cooperation Treaty
PCT/US2006/33560
Filed on 2006-08-30

Accelerating agent of neurogenesis

  • Read more about Accelerating agent of neurogenesis
Japan
2005-181699
Filed on 2005-06-22

17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE

  • Read more about 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE
Japan
2004-355724
Filed on 2004-12-08

Human P53 Mutations and a Genetic System in Yeast for Functional Identification of Human P53 Mutations

  • Read more about Human P53 Mutations and a Genetic System in Yeast for Functional Identification of Human P53 Mutations
Australia
2006202361
Filed on 2006-06-02

New Biological Potent Analogues Of The DMT-TIC Pharmaphore And Methods Of Use

  • Read more about New Biological Potent Analogues Of The DMT-TIC Pharmaphore And Methods Of Use
US Application 11/280,752
Filed on 2005-11-16

Soluble Epoxide HydrolaseInhibitors As Novel Therapeutic Agents For Management Of Systemic Hypertension

  • Read more about Soluble Epoxide HydrolaseInhibitors As Novel Therapeutic Agents For Management Of Systemic Hypertension
US Application 11/189,964
Filed on 2005-07-25

Glyceraldehyde 3-phosphate Dehydrogenase-S (GAPDS), A Glycolytic Enzyme Expressed Only In Male Germ Cells Is A Target For Male Contraception

  • Read more about Glyceraldehyde 3-phosphate Dehydrogenase-S (GAPDS), A Glycolytic Enzyme Expressed Only In Male Germ Cells Is A Target For Male Contraception
US Application 11/140,417
Filed on 2005-05-27

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIEHS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health